Merck Sharp & Dohme LLC — Federal Contractor Profile
MERCK SHARP & DOHME LLC: $1156.16B in Federal Contracts, Primarily in Pharmaceuticals
Contractor Overview
Total Contract Value: $1,156,157,599,846 ($1.2T)
Total Awards: 832
Company Profile
MERCK SHARP & DOHME LLC is a pharmaceutical company with a significant presence in federal government contracts, primarily through the provision of medical supplies, pharmaceuticals, and related services. The company's core capabilities include drug development, manufacturing, and distribution, with a focus on supporting public health initiatives and medical research. Given the substantial contract value and the number of contracts, MERCK SHARP & DOHME LLC plays a critical role in federal health and medical programs. The company's contract patterns reveal a strong dependency on a few key agencies, which could pose risks if there are changes in agency priorities or funding. The company's track record suggests a consistent performance in delivering medical supplies and services, but the lack of recent contracts and the absence of competitive wins indicate a potential shift in their business strategy or market position. Overall, MERCK SHARP & DOHME LLC's role in government spending is significant, and their performance and strategic direction are closely watched by government officials and taxpayers.
Specializations
- Pharmaceuticals
- Medical Supplies
- Drug Development
- Manufacturing
- Distribution
- Public Health Initiatives
- Medical Research
- Vaccines
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 0% (all contracts are sole-source)
Agency Concentration: high
Growth Trajectory: stable
Sole Source Rate: 100%
Recompete Rate: 0% (no recompetes/renewals)
Competitive Position
MERCK SHARP & DOHME LLC is a dominant player in the pharmaceutical sector, particularly in federal government contracts. The company's sole-source contracts and large contract sizes indicate a strong market position and the ability to meet specific needs that other competitors cannot. However, the lack of competitive wins suggests that the company may be facing challenges in demonstrating value to taxpayers and may need to adapt its business strategy to remain competitive.
Value to Taxpayers
MERCK SHARP & DOHME LLC provides essential medical supplies and pharmaceuticals to the federal government, which is critical for public health initiatives and medical research. The company's large contract sizes and sole-source status suggest that they are meeting specific needs that other competitors cannot. However, the lack of competitive wins and recent contracts raises concerns about whether the company is providing good value for taxpayer money. The company's performance history and track record suggest that they are capable of delivering high-quality products and services, but there is a need for more transparency and competition to ensure that taxpayers are getting the best value.
Agency Relationships
MERCK SHARP & DOHME LLC has a strong dependency on a few key agencies, including the Department of Health and Human Services (HHS) and the Department of Defense (DOD). These agencies rely on the company for critical medical supplies and pharmaceuticals, which could pose risks if there are changes in agency priorities or funding. The high concentration of agency clients suggests that the company may be vulnerable to shifts in government spending and priorities.
Red Flags
- 100% sole-source contracts: The company's reliance on sole-source contracts raises concerns about competition and potential cost overruns.
- No recent competitive wins: The lack of competitive wins suggests that the company may be facing challenges in demonstrating value to taxpayers and may need to adapt its business strategy.
- High agency concentration: The company's strong dependency on a few key agencies could pose risks if there are changes in agency priorities or funding.
Green Flags
- Strong performance history: The company's track record suggests that they are capable of delivering high-quality products and services.
- Critical medical supplies: The company provides essential medical supplies and pharmaceuticals to the federal government, which is critical for public health initiatives and medical research.
- Large contract sizes: The company's large contract sizes indicate that they are meeting specific needs that other competitors cannot.
Key Contracts
MERCK SHARP & DOHME LLC's most significant contracts include those with the Department of Health and Human Services (HHS) and the Department of Defense (DOD). These contracts involve the provision of medical supplies, pharmaceuticals, and related services, which are critical for public health initiatives and medical research. The company's track record of delivering these products and services on time and within budget suggests that they are capable of meeting the needs of the federal government. However, the lack of recent contracts and the absence of competitive wins indicate a potential shift in their business strategy or market position. The company's performance and strategic direction are closely watched by government officials and taxpayers, and there is a need for more transparency and competition to ensure that taxpayers are getting the best value.
Frequently Asked Questions
What does MERCK SHARP & DOHME LLC do for the federal government?
MERCK SHARP & DOHME LLC provides medical supplies, pharmaceuticals, and related services to the federal government, primarily through the Department of Health and Human Services (HHS) and the Department of Defense (DOD). The company's core capabilities include drug development, manufacturing, and distribution, with a focus on supporting public health initiatives and medical research.
How much taxpayer money does MERCK SHARP & DOHME LLC receive?
MERCK SHARP & DOHME LLC has received a total of $1156.16 billion in federal contracts, with an average contract size of $1,38,96,12,500. The company has won all contracts through sole-source awards, with no recent competitive wins.
Is MERCK SHARP & DOHME LLC good value for taxpayer money?
MERCK SHARP & DOHME LLC provides essential medical supplies and pharmaceuticals to the federal government, which is critical for public health initiatives and medical research. However, the company's large contract sizes and sole-source status raise concerns about competition and potential cost overruns. The lack of recent competitive wins and the absence of recompetes/renewals suggest that the company may be facing challenges in demonstrating value to taxpayers and may need to adapt its business strategy.
How does MERCK SHARP & DOHME LLC win its contracts?
MERCK SHARP & DOHME LLC wins its contracts through sole-source awards, with no recent competitive wins. The company's large contract sizes and critical nature of the products and services they provide likely contribute to their ability to secure sole-source contracts.
What agencies use MERCK SHARP & DOHME LLC most?
MERCK SHARP & DOHME LLC has a strong dependency on a few key agencies, including the Department of Health and Human Services (HHS) and the Department of Defense (DOD). These agencies rely on the company for critical medical supplies and pharmaceuticals, which could pose risks if there are changes in agency priorities or funding.
What are the risks of relying on MERCK SHARP & DOHME LLC?
The company's sole-source contracts and high agency concentration pose risks if there are changes in agency priorities or funding. The lack of recent competitive wins and the absence of recompetes/renewals suggest that the company may be facing challenges in demonstrating value to taxpayers and may need to adapt its business strategy. There is a need for more transparency and competition to ensure that taxpayers are getting the best value.
How does MERCK SHARP & DOHME LLC compare to similar contractors?
MERCK SHARP & DOHME LLC is a dominant player in the pharmaceutical sector, particularly in federal government contracts. The company's sole-source contracts and large contract sizes indicate a strong market position and the ability to meet specific needs that other competitors cannot. However, the lack of competitive wins suggests that the company may be facing challenges in demonstrating value to taxpayers and may need to adapt its business strategy to remain competitive.
Recent Federal Contracts
Merck Sharp & Dohme LLC has 13 federal contracts on record. Below are the largest awards: